These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35429496)

  • 21. Predicting a Positive Antibody Response After 2 SARS-CoV-2 mRNA Vaccines in Transplant Recipients: A Machine Learning Approach With External Validation.
    Alejo JL; Mitchell J; Chiang TP; Chang A; Abedon AT; Werbel WA; Boyarsky BJ; Zeiser LB; Avery RK; Tobian AAR; Levan ML; Warren DS; Massie AB; Moore LW; Guha A; Huang HJ; Knight RJ; Gaber AO; Ghobrial RM; Garonzik-Wang JM; Segev DL; Bae S
    Transplantation; 2022 Oct; 106(10):e452-e460. PubMed ID: 35859275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of anti-SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients.
    Bertrand D; Laurent C; Lemée V; Lebourg L; Hanoy M; Le Roy F; Nezam D; Pruteanu D; Grange S; de Nattes T; Lemoine M; Candon S; Guerrot D
    Kidney Int; 2022 Aug; 102(2):440-442. PubMed ID: 35618097
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody Response to SARS-CoV-2 mRNA Vaccine Among Kidney Transplant Recipients: A Retrospective Cohort Study at a Single Transplant Institute in Japan.
    Ishida H; Furusawa M; Unagami K; Omoto K; Iizuka J; Takagi T
    Exp Clin Transplant; 2022 May; 20(5):463-471. PubMed ID: 35607795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response.
    Midtvedt K; Vaage JT; Heldal K; Munthe LA; Lund-Johansen F; Åsberg A
    Am J Transplant; 2022 Nov; 22(11):2704-2706. PubMed ID: 35533010
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody Avidity and Neutralizing Response against SARS-CoV-2 Omicron Variant after Infection or Vaccination.
    Dapporto F; Marchi S; Leonardi M; Piu P; Lovreglio P; Decaro N; Buonvino N; Stufano A; Lorusso E; Bombardieri E; Ruello A; Viviani S; Molesti E; Trombetta CM; Manenti A; Montomoli E
    J Immunol Res; 2022; 2022():4813199. PubMed ID: 36093434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. COVID-19 Vaccines in Pancreatic Transplant Recipients: A Single-Center Observative Study.
    Matejak-Górska M; Zielonka M; Górska H; Durlik M
    Transplant Proc; 2022 May; 54(4):925-929. PubMed ID: 35437149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study.
    Rozen-Zvi B; Yahav D; Agur T; Zingerman B; Ben-Zvi H; Atamna A; Tau N; Mashraki T; Nesher E; Rahamimov R
    Clin Microbiol Infect; 2021 Aug; 27(8):1173.e1-1173.e4. PubMed ID: 33957273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Humoral and Cellular Immune Response to a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients Taking Belatacept.
    Mitchell J; Kim J; Alejo JL; Chiang TP; Karaba AH; Blankson JN; Aytenfisu TY; Chang A; Abedon AT; Avery RK; Tobian AA; Massie AB; Levan ML; Warren DS; Garonzik-Wang JM; Segev DL; Werbel WA
    Transplantation; 2022 May; 106(5):e264-e265. PubMed ID: 35289776
    [No Abstract]   [Full Text] [Related]  

  • 29. Neutralization of SARS-CoV-2 Omicron and Delta Variants in Relation to Vaccine-Induced Antibody Levels in Kidney Transplant Recipients and Healthy Controls.
    Pedersen RM; Bang LL; Tornby DS; Kierkegaard H; Nilsson AC; Johansen IS; Sydenham TV; Jensen TG; Justesen US; ; Bistrup C; Andersen TE
    Microbiol Spectr; 2022 Oct; 10(5):e0131422. PubMed ID: 36169412
    [No Abstract]   [Full Text] [Related]  

  • 30. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
    Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Humoral Response After Five Successive Doses of SARS-CoV-2 mRNA Vaccine in Kidney Transplant Patients.
    Cazorla JM; Villanego F; Aguilera A; Garcia T; Orellana C; Trujillo T; Gómez AM; Mazuecos A
    Transplantation; 2023 Jul; 107(7):e188-e189. PubMed ID: 37170412
    [No Abstract]   [Full Text] [Related]  

  • 32. COVID-19 after two doses of mRNA vaccines in kidney transplant recipients.
    Mehta RB; Silveira FP
    Am J Transplant; 2021 Dec; 21(12):4102-4104. PubMed ID: 34331745
    [No Abstract]   [Full Text] [Related]  

  • 33. Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
    Kumar D; Ferreira VH; Hall VG; Hu Q; Samson R; Ku T; Ierullo M; Majchrzak-Kita B; Tomlinson G; Gingras AC; Humar A
    Ann Intern Med; 2022 Feb; 175(2):226-233. PubMed ID: 34807716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.
    Hoffman TW; Meek B; Rijkers GT; van Kessel DA
    Transpl Immunol; 2022 Jun; 72():101599. PubMed ID: 35390480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.
    Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S
    Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674
    [No Abstract]   [Full Text] [Related]  

  • 36. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
    Thuluvath PJ; Robarts P; Chauhan M
    J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?
    Ogura W; Ohtsuka K; Matsuura S; Okuyama T; Matsushima S; Yamasaki S; Miyagi H; Sekiguchi K; Ohnishi H; Watanabe T
    Viruses; 2022 May; 14(5):. PubMed ID: 35632698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody response to a third dose of SARS-CoV-2 vaccine in heart and lung transplant recipients.
    Alejo JL; Ruck JM; Chiang TPY; Abedon AT; Kim JD; Avery RK; Tobian AAR; Warren DS; Levan ML; Massie AB; Garonzik-Wang JM; Segev DL; Werbel WA
    Clin Transplant; 2022 Nov; 36(11):e14818. PubMed ID: 36073912
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients.
    Cholankeril G; Al-Hillan A; Tarlow B; Abrams D; Jacobs JS; Flores NP; Rana A; Kanwal F; Goss JA
    Liver Transpl; 2022 Jan; 28(1):123-126. PubMed ID: 34724328
    [No Abstract]   [Full Text] [Related]  

  • 40. Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipients.
    McCune TR; Bray RA; Baran DA; Toepp AJ; Forte SJ; Gilgannon LT; Williams T; Chen S; Sadr H; Gebel HM; Herre JM
    Transpl Immunol; 2022 Dec; 75():101722. PubMed ID: 36152939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.